31.01.2025 12:18:43

Revvity Guides FY25 Below Estimates - Update

(RTTNews) - While reporting financial results for the fourth quarter on Friday, biotechnology company Revvity, Inc. (RVTY) initiated its adjusted earnings and total revenue guidance for the full-year 2025.

For fiscal 2025, the company now projects adjusted earnings in a range of $4.90 to $5.00 per share on total revenues between $2.80 billion and $2.85 billion.

On average, analysts polled expect the company to report earnings of $5.00 per share on revenues of $2.86 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Analysen zu PerkinElmer Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

PerkinElmer Inc. 98,54 -2,39% PerkinElmer Inc.